Metabolite identification studies are crucial during drug discovery and development. These studies facilitate soft-spot identification and help to design compounds with favorable properties. They also help identify pharmacologically active and chemically reactive metabolites that may have potential toxicity or other liabilities. Eurofins Advinus provides metabolite identification studies at both, early discovery and preclinical development, stages. The team is highly experienced and has expertise in chemistry and biochemistry to support such investigations. The Eurofins Advinus Discovery Services team is here to help you understand the biotransformation pathways of small molecules and elucidate metabolite structures in various biological matrices by Metabolite Profiling. Our team has expertise in - 🔵 Metabolite Identification in sub-cellular fractions, hepatocytes, and in vivo samples 🔵 Cross-species comparison in metabolism 🔵 Tentative structure prediction using LCMS/MS 🔵 Reactive metabolite trapping using Glutathione 🔵 Assays conducted with radiolabeled and unlabeled compounds For more details, email us at [email protected] “It has been observed that fake employment offers are being made, via email and otherwise, by misusing Eurofins Advinus name. Please be informed that Eurofins Advinus does not require any payment or fees from prospective candidates and Eurofins Advinus does not send any recruitment email from generic email addresses other than email addresses ending with “advinus.com”. ”
